JAG1 and breast carcinoma: Another recent study demonstrated that antibody-specific inhibition of JAG1 sensitizes chemoresistance of TNBC cells in vivo in mice, showcasing an important role for JAG1 and the Notch pathway in promoting chemoresistance in breast cancer [44].